
Sections of rat brain transplanted with human cells in a preclinical model of PD are being prepared for analysis
Despite challenges, new advances in stem cell biology and genetic engineering show potential for better cell replacement therapies, say experts in a special supplement to JPD
Cell replacement may play an increasing role in alleviating the motor symptoms of Parkinson’s disease (PD) in future. Writing in an open access special supplement to the Journal of Parkinson’s Disease, experts describe how newly developed stem cell technologies could be used to treat the disease and discuss the great promise, as well as the significant challenges, of stem cell treatment.
The most common PD treatment today is based on enhancing the activity of the nigro-striatal pathway in the brain with dopamine-modulating therapies, thereby increasing striatal dopamine levels and improving motor impairment associated with the disease. However, this treatment has significant long-term limitations and side effects. Stem cell technologies show promise for treating PD and may play an increasing role in alleviating at least the motor symptoms, if not others, in the decades to come.
“We are in desperate need of a better way of helping people with PD. It is on the increase worldwide. There is still no cure, and medications only go part way to fully treat incoordination and movement problems,” explained co-authors Claire Henchcliffe, MD, DPhil, from the Department of Neurology, Weill Cornell Medical College, and Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA; and Malin Parmar, PhD, from the Wallenberg Neuroscience Center and Lund Stem Cell Center, Lund University, Lund, Sweden. “If successful, using stem cells as a source of transplantable dopamine-producing nerve cells could revolutionize care of the PD patient in the future. A single surgery could potentially provide a transplant that would last throughout a patient’s lifespan, reducing or altogether avoiding the need for dopamine-based medications.”
The authors have analyzed how newly developed stem cell technologies could be used to treat PD, and how clinical researchers are moving very quickly to translate this technology to early clinical trials. In the past, most transplantation studies in PD used human cells from aborted embryos. While these transplants could survive and function for many years, there were scientific and ethical issues: fetal cells are in limited supply, and they are highly variable and hard to quality control. Only some patients benefited, and some developed side effects from the grafts, such as uncontrollable movements called dyskinesias.
Recent strides in stem cell technology mean that quality, consistency, activity, and safety can be assured, and that it is possible to grow essentially unlimited amounts of dopamine-producing nerve cells in the laboratory for transplantation. This approach is now rapidly moving into initial testing in clinical trials. The choice of starting material has also expanded with the availability of multiple human embryonic stem cell lines, as well as the possibilities for producing induced pluripotent cells, or neuronal cells from a patient’s own blood or skin cells. The first systematic clinical transplantation trials using pluripotent stem cells as donor tissue were initiated in Japan in 2018.
“We are moving into a very exciting era for stem cell therapy,” commented Dr. Parmar. “The first-generation cells are now being trialed and new advances in stem cell biology and genetic engineering promise even better cells and therapies in the future. There is a long road ahead in demonstrating how well stem cell-based reparative therapies will work, and much to understand about what, where, and how to deliver the cells, and to whom. But the massive strides in technology over recent years make it tempting to speculate that cell replacement may play an increasing role in alleviating at least the motor symptoms, if not others, in the decades to come.”
“With several research groups, including our own centers, quickly moving towards testing of stem cell therapies for PD, there is not only a drive to improve what is possible for our patients, but also a realization that our best chance is harmonizing efforts across groups,” added Dr. Henchcliffe. “Right now, we are just talking about the first logical step in using cell therapies in PD. Importantly, it could open the way to being able to engineer the cells to provide superior treatment, possibly using different types of cells to treat different symptoms of PD like movement problems and memory loss.”
“This approach to brain repair in PD definitely has major potential, and the coming two decades might also see even greater advances in stem cell engineering with stem cells that are tailor-made for specific patients or patient groups,” commented Patrik Brundin, MD, PhD, Van Andel Research Institute, Grand Rapids, MI, USA, and J. William Langston, MD, Stanford Udall Center, Department of Pathology, Stanford University, Palo Alto, CA, USA, Editors-in-Chief of the Journal of Parkinson’s Disease. “At the same time, there are several biological, practical, and commercial hurdles that need circumventing for this to become a routine therapy.”
Learn more: Can We Repair the Brain? The Promise of Stem Cell Technologies for Treating Parkinson’s Disease
The Latest on: Stem cell technologies
[google_news title=”” keyword=”stem cell technologies” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Stem cell technologies
- Spatial Technology Offers Spectacular Insightson February 6, 2023 at 1:02 am
Besides providing dazzling visuals, spatial technology—the latest omics craze—is digging into rich data sets and uncovering meaningful results.
- Global Animal Stem Cell Therapy Market Growth (Size and Outlook) 2023 Research Report by Sales, Revenue, Price, Gross Margin and Forecast to 2029on February 5, 2023 at 10:55 pm
Feb 06, 2023 (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry." Global “Animal Stem Cell Therapy ...
- Asia Pacific Stem Cell Therapy Market to Generate Revenue of Over US$ 3,420 Million by 2031 | Astute Analyticaon February 3, 2023 at 3:30 am
Pages Research Study] The Asia Pacific stem cell therapy market was valued at US$ 1,453.61 million in 2021 and is expected to reach US$ 3,420.05 million by 2031, growing at a compound annual growth ...
- Could We Slow Aging by Rejuvenating Old Blood Stem Cells?on February 2, 2023 at 6:54 am
Previous research has shown that blood from young people can have rejuvenating and restorative effects when added to older bodies. Older hearts and muscles increase in strength while cognitive skills ...
- CuSTOM; Creating a healthier society by accelerating the translation of organoid technologyon February 1, 2023 at 5:19 am
In this interview, we speak to Magdalena Kasendra at the CuSTOM Accelerator, about the organoid technology and how it has the power the revolutionize healthcare.
- Chinese scientists’ stem cell experiment raises hopes for effective Parkinson’s disease treatmenton January 31, 2023 at 8:00 pm
Monkeys suffering from the degenerative disease found their mobility greatly improved just weeks after receiving the first stem cell transplants If the treatment works on humans, researchers say the ...
- Stem Cell Technology Is Saving Dogs With Canceron January 31, 2023 at 1:29 pm
At the National University of Singapore, scientists are using stem cell technology to treat dog cancer. Amazingly, researchers from the Yong Loo Lin School of Medicine bio-engineered stem cells to ...
- Stem cell and gene editing technology could bring back extinct Dodoon January 31, 2023 at 9:55 am
This is the promise of the Dallas, Texas-based startup Colossal Biosciences, who are looking to use stem cell technology and gene editing to “de-extinct” the hapless species as part of a £ ...
- What’s Holding Cell Therapies Back? A Look Into The Evolution And Future Of Stem Cell Techon January 31, 2023 at 2:46 am
While cell therapies have already come a long way, there is much to be done to streamline clinical trial submissions and approvals.
- Stem Cell Media Market 2023 Advance Technology, Latest Trend and Future Expansion by 2028on January 29, 2023 at 4:06 pm
Final Report will add the analysis of the impact of Russia-Ukraine War and COVID-19 on this Stem Cell Media industry.
via Bing News